Canada Pharmacies Foresee Great Savings with Less Osteoporosis Screening Tests for Women

American women over the age of 50 years have to undergo frequent osteoporosis screening tests to check for erosion of bone density. Canada pharmacies point out follow-up tests costing US $250 were putting huge burden on people as well as the government. However, recent research reveals American women are now able to skip these costly follow-up tests for a period extending up to 15 years. Findings are now able to ascertain the exact period advisers and medical practitioners should recommended screening tests for osteoporosis in women over the age of 50 years.

Government Backed Research Detects Early Warning Signs Of Osteoporosis

The medical fraternity wants a definite system to be incorporated to detect and prescribe medical tests for osteoporosis based on individual needs and accurate results. The actual test at present takes around 10 minutes with very minimum exposure to radiation. Insurance burden is shared between individuals as well as private and government bodies. For example, Medicare allows an osteoporosis screening test to be conducted once in two years.

Findings from the new research clearly indicate a frequency of two years is not necessary in many cases. Undergoing tests without apparent indication of bone density erosion was suggested earlier to avoid unexpected complications. The National Osteoporosis Foundation reported nearly half the number of women in United States over the age of 50 years is likely to experience fracture on account of osteoporosis. People do buy Caltrate from canada pharmacies to slow down the rate of age-related bone loss.

The present ongoing study is being conducted on 5,000 women age 67 years or older. The health study began in the 1980s, and participants did not have osteoporosis at the start. Risk factors for osteoporosis were analyzed during the first test. Volunteers were then followed over a period of 15 years. Researchers categorized participants as per involved risk factor.

Women demonstrating very little signs of osteoporosis during the initial test could safely have another test after 15 years. Researchers then categorized participants into two additional groups, one with moderate risk to be screened again after five years and the other high-risk group to be screened annually, if required. By categorizing patients immediately after first screening, the exact period of follow-up tests could be determined, thereby affording tremendous savings over the long term. Women over the age of 85 years with moderate risk could opt for osteoporosis tests after three years instead of five.

Postmenopausal Women Have Less Risk after Preliminary Screening

Postmenopausal women showed minimum risk of osteoporosis over the study period. Findings published in the New England Journal of Medicine presented a balanced view expressed by researchers from University of North Carolina. They reasoned consequent tests should not be avoided, if preliminary tests did indicate follow-up requirement. The study, however, does establish postmenopausal women have less risk after the first screening. It effectively accounted for approximately half the US women over the age of 65 years.

Accuracy of the test also depended on other factors such as slim body, smoking habits, earlier experience of fracture or broken bone, and being on medical prescription leading to erosion of bone density. Canada pharmacies believe accuracy of the initial test will determine frequency of repeat tests, but the extended research period does provide a good platform to establish a precise follow-up structure.

Abram Gravin is specializing in writing articles on how to save on medication by buying from canadian pharmacy. For more information about the author and savings on online canadian pharmacy please visit http://www.canadapharmacyonline.com